Menu Search
Equities

ValiRx PLC

VAL:LSE

ValiRx PLC

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (GBX)3.45
  • Today's Change-0.175 / -4.83%
  • Shares traded3.45m
  • 1 Year change-66.34%
  • Beta0.9877
Data delayed at least 20 minutes, as of Apr 18 2024 14:50 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Cash flow in GBPView more

In 2022, ValiRx PLC increased its cash reserves by 91.60%, or 543.81k. Cash Flow from Financing totalled 2.26m or -- of revenues. In addition the company used 1.71m for operations while cash from investing was breakeven.
Cash flow per share-0.0235
Price/Cash flow per share--
Book value per share0.0411
Tangible book value per share0.0174
More ▼

Balance sheet in GBPView more

ValiRx PLC uses little debt in its capital structure as supported by a debt to capital ratio of 0.72%.
Current ratio13.37
Quick ratio--
Total debt/total equity0.0069
Total debt/total capital0.0072
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.